Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-029345
Filing Date
2025-03-28
Accepted
2025-03-28 16:00:21
Documents
3
Period of Report
2025-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2510655d1_6k.htm 6-K 15688
2 EXHIBIT 99.1 tm2510655d1_ex99-1.htm EX-99.1 3825
3 GRAPHIC tm2510655d1_ex99-1img001.jpg GRAPHIC 3315
  Complete submission text file 0001104659-25-029345.txt   25279
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41359 | Film No.: 25785647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)